表紙
市場調査レポート

先進創傷管理技術市場

Markets for Advanced Wound Management Technologies

発行 BCC Research 商品コード 219298
出版日 ページ情報 英文 179 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
先進創傷管理技術市場 Markets for Advanced Wound Management Technologies
出版日: 2014年06月06日 ページ情報: 英文 179 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

2013年における世界の先進創傷管理市場総額は、2011年の79億米ドルから上昇し、86億米ドルに達しました。同市場額は、今後5.6%のCAGRで成長し、2018年までに113億米ドルに達する見込みです。

当レポートでは、世界における先進創傷ケアと関連する技術市場について包括的に分析し、市場の動向の分析とCAGR予測、さまざまな製品・セグメントに関する情報、主要企業の主要戦略・競合分析・発展の分析などをまとめ、お届けいたします。

第1章 イントロダクション

第2章 サマリー

  • 主要市場とイントロダクション

第3章 業界概要

  • 創傷管理の歴史
  • 外皮系
  • 創傷の分類
  • 創傷治癒プロセス
    • 治癒の段階
  • 創傷治癒に影響する一般的な健康指標:米国のデータ
    • 喫煙
    • 年齢
    • 栄養状態
    • 肥満
    • 体液・電解質平衡
    • 免疫抑制者・免疫不全者
    • 薬物療法
    • 放射線療法
  • 創傷治癒における栄養
  • 創傷治癒の合併症
  • 創傷の種類・統計
    • 急性創傷
    • 慢性創傷
  • 火傷
    • 火傷の分類
    • 火傷治癒の段階
    • 創傷データ

第4章 市場動向

  • 医療費償還問題
  • 人口統計
  • 人口の高齢化
  • 装置の政府規制
  • 国際的な幹細胞研究

第5章 技術・新たな開発

  • 新たな開発・研究
    • 幹細胞研究
    • 遺伝子療法
    • LED
    • 体外vs.体外(in vivo vs.in vitro)
    • 体外
    • 体内
  • 軍の創傷管理
    • 戦場における創傷治療
  • 代替的創傷治療
    • ウジ虫療法
    • ヒル療法
    • ミツバチ療法(アピセラピー)
  • 技術
    • 現在の技術活用
  • 特許分析

第6章 市場セグメント

  • 先進被覆材技術
    • 生物学的創傷治療
    • 開発中の製品
    • 市場分析・結論
    • 合成被覆材
    • 天然被覆材
  • 外科的シーラント・接着剤
    • 製品説明
    • 開発中の製品
    • 市場分析・結論
  • 抗接着・その他関連の創傷治癒製品
  • 創傷治癒製品

第7章 市場サマリー

  • 先進創傷ケア市場全体の分析
  • 世界市場:地域別
  • 業界参入企業:タイプ別

第8章 企業プロファイルと概要

  • 3M HEALTH CARE
  • BARD MEDICAL DIVISION
  • BAXTER INTERNATIONAL INC.
  • COLOPLAST A/S
  • CONVATEC INC.
  • COVIDIEN PLC
  • CRYOLIFE INC.
  • DERMA SCIENCES INC.
  • ETHICON INC.
  • GENZYME BIOSURGERY-A SANOFI COMPANY
  • HARTMANN GROUP
  • INTEGRA LIFE SCIENCES CORP.
  • KINETIC CONCEPTS INC. (LIFECELL)
  • ORGANOGENESIS INC.
  • MOLNLYCKE HEALTH CARE
  • SHIRE REGENERATIVE MEDICINE
  • SMITH & NEPHEW PLC

第9章 付録

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHM011H

The global market for advanced wound management totaled $8.6 billion in 2013, up from 2011's value of $7.9 billion. By 2018, this market is likely to reach $11.3 billion, a compound annual growth rate (CAGR) of 5.6%.

This report provides:

  • An overview of the global markets for advanced wound care and related technologies.
  • Analyses of global market trends, with data from 2012 and 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Information on various products and segments in the market such as biological dressings, surgical sealants, synthetic dressings, anti-adhesion products and other related wound healing products and devices.
  • Analyses of key strategies, competitive insights, and developments of key companies in the market.
  • A look at how new technological products are competing in a fast track market that seeks to improve the quality of life for millions of individuals needing both acute and chronic wound care.

REPORT SCOPE

INTRODUCTION

STUDY GOALS AND OBJECTIVES

This updated BCC Research report provides an overview of advanced wound care products, detailed market analyses and discussions of competitive environments. The study includes information about significant products, players, issues and trends and other information affecting the wound care industry.

REASONS FOR DOING THE STUDY

Advanced wound management technologies have emerged from the shadows to become, in the last 30 years, significant products in the treatment and management of wounds. While conventionally made wound management product proteins are considerable and generally less expensive, new products and biotechnological advancements are continuing to revolutionize the wound management market. New technological products are competing in a fast track market that seeks to improve the quality of life for millions of individuals needing both acute and chronic wound management.

Ongoing patient management studies will increase the number of indications, and keeping in touch with these applications for the various advanced wound management products is good business practice. This study will provide its readers with the knowledge to adequately view and assess the advanced wound management movement and provide insight into market potential.

SCOPE OF REPORT

This document is designed to be a helpful business tool that will provide a thorough evaluation of the advanced wound management market. The scope of this study is U.S. based and identifies markets in four general segments:

  • Advanced dressings.
  • Surgical sealants.
  • Anti-adhesion products and other related wound healing products.
  • Wound healing devices.

Each market segment provides detailed information based on product categories, product use, forecasts and competitive analyses.

Advanced wound management deals with those products that involve new techniques and therapies, are of benefit in healing wounds, and result in overall lower costs for management. They incorporate biotechnological advancements and improved methods for dealing with wounds. Products in this study are considered to be at the forefront of wound management technology.

Traditional wound management products, those that have previously been used in the marketplace, are not addressed in this analysis. Industry experts classify "advanced wound management products" as those that include biological dressings, surgical sealants, synthetic dressings, anti-adhesion products and other related wound healing products

METHODOLOGY

Information for this report was obtained through primary and secondary data collection methods. Primary methods included interviews with more than 50 key executives, product managers, clinical specialists and other related key personnel involved in the wound management industry. Secondary methods included published literature, investment reports, company literature, and various business journals that have emphases on wound management and related areas.

Data for this report relates to the global market in U.S. dollars at the manufacturers' level. The base year of the report is 2013, with historical data provided for 2011 and 2012 and forecast data provided for 2018. Historical, base year and forecast data are provided for each market segment of the report. Growth rates are determined through a compilation of data including past trends, future trends, demographics, incidence, mortality, products in research and development, current product growth, etc. Competitor market share estimates are provided for each market segment for the 2013 base year.

PREVIOUS VERSIONS OF THIS REPORT INCLUDE:

  • PHM011F Markets for Advanced Wound Care Technologies - published 2009
  • PHM011G Markets for Advanced Wound Care Technologies - published 2011

ANALYSTS' CREDENTIALS

TRACY COTTHOFF

Tracy Cotthoff is an experienced wound care nurse in a high-volume burn center in Portland, Ore. Ms. Cotthoff has been in the medical field for over 21 years. This experience has given her a vast knowledge of medical practices and advances in the industry and new technologies. Her experience in the medical field includes EMT training and nursing, including critical care nursing, which has allowed for her substantial insight into the workings of the healthcare industry. Ms. Cotthoff's experience and knowledge in the wound care industry is pivotal in providing an in-depth review of the wound care industry, its trends, opportunities and new developments.

MELISSA ELDER

Melissa Elder is an experienced healthcare market analyst specializing in prescription and over-the-counter pharmaceuticals, medical devices and emerging healthcare technologies. Ms. Elder has nearly 20 years of experience in the healthcare industry, specializing in market research for the past 14 years. This experience has given her a strong understanding of pharmaceutical market analysis. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare markets.

Table of Contents

CHAPTER 1 INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • METHODOLOGY
  • PREVIOUS VERSIONS OF THIS REPORT INCLUDE:
  • RELATED BCC RESEARCH REPORTS
  • ANALYSTS' CREDENTIALS
    • TRACY COTTHOFF
    • MELISSA ELDER
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 SUMMARY

  • MAJOR MARKETS AND INTRODUCTION
  • SUMMARY TABLE GLOBAL ADVANCED WOUND MANAGEMENT MARKET BY MAJOR MARKET SEGMENT, THROUGH 2018 ($ MILLIONS)
  • SUMMARY FIGURE GLOBAL ADVANCED WOUND MANAGEMENT MARKET BY MAJOR MARKET SEGMENT, 2011-2018 ($ MILLIONS)

CHAPTER 3 INDUSTRY OVERVIEW

  • HISTORICAL WOUND MANAGEMENT OVERVIEW
  • THE INTEGUMENTARY SYSTEM
  • FIGURE 1 SKIN LAYERS
  • WOUND CLASSIFICATIONS
  • THE PROCESS OF WOUND HEALING
    • STAGES OF HEALING
      • Inflammatory Phase
      • Destructive Phase
      • Proliferative Phase
      • Maturation
      • Healing by Secondary Intention
      • Factors Affecting Wound Healing
  • GENERAL HEALTH INDICATORS AFFECTING WOUND HEALING: U.S. DATA
    • SMOKING
    • TABLE 1 PERCENT OF SMOKERS IN THE U.S. POPULATION 18 AND OLDER BY AGE AND GENDER, 2009
    • AGE
    • TABLE 2 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 1900-2050 (THOUSANDS)
    • FIGURE 2 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 1900-2050 (THOUSANDS)
    • TABLE 3 ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH WITH PROJECTIONS BY GENDER, 2000 AND 2020 (YEARS)
    • FIGURE 3 ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH WITH PROJECTIONS BY GENDER, 2000 AND 2020 (YEARS)
    • NUTRITIONAL STATUS
    • OBESITY
    • FLUID AND ELECTROLYTE BALANCE
    • IMMUNOSUPPRESSED OR COMPROMISED INDIVIDUALS
    • DRUG THERAPY
    • RADIATION THERAPY
  • NUTRITION IN WOUND HEALING
  • TABLE 4 PATIENT HISTORY FOR NUTRITIONAL ASSESSMENT
  • COMPLICATIONS OF WOUND HEALING
    • SCARRING
    • ADHESIONS
    • DEHISCENCE
    • EVISCERATION
    • INFECTION
    • HEMORRHAGE
    • FISTULAS
  • WOUND TYPES AND STATISTICS
    • ACUTE WOUNDS
      • Surgical Wounds/Incision
        • Surgical Wound Classifications
        • TABLE 5 SURGICAL WOUND CLASSIFICATIONS
      • Traumatic Wounds
      • Lacerations
      • Abrasions
      • Contusions
      • Necrotizing Fasciitis
      • Toxic Epidermal Necrolysis
    • CHRONIC WOUNDS
      • Pressure Ulcers
      • TABLE 6 COMMON SITES FOR PRESSURE ULCER DEVELOPMENT (% OF OCCURRENCE)
        • Staging
        • TABLE 7 PRESSURE ULCER STAGING
      • Venous Insufficiency Ulcers
      • Arterial Ulcers
      • Diabetic or Neuropathic Ulcers
  • BURN WOUNDS
    • BURN CLASSIFICATIONS
    • TABLE 8 BURN CLASSIFICATIONS
    • STAGES OF BURN HEALING
    • WOUND FIGURES
      • Acute Wounds
      • Chronic Wounds
      • Burn Wounds
      • Age and Wounds by Type
      • TABLE 9 ESTIMATED INCIDENCE BY AGE GROUP AND WOUND TYPE (% DISTRIBUTION)
      • FIGURE 4 ESTIMATED INCIDENCE BY AGE GROUP AND WOUND TYPE (% DISTRIBUTION)

CHAPTER 4 MARKET TRENDS

  • REIMBURSEMENT ISSUES
  • DEMOGRAPHICS
  • TABLE 10 GLOBAL POPULATION BY SELECTED COUNTRY, THROUGH 2015 ($ MILLIONS)
  • FIGURE 5 GLOBAL POPULATION BY SELECTED COUNTRY, 2010 AND 2015 (MILLIONS)
  • THE AGING POPULATION
  • TABLE 11 ESTIMATED GLOBAL POPULATION AND ANNUAL GROWTH BY SELECTED AGE GROUP AND SELECTED YEARS, THROUGH 2030 ($ MILLIONS)
  • FIGURE 6 ESTIMATED GLOBAL POPULATION BY SELECTED AGE GROUP AND SELECTED YEARS, 2000-2030 (MILLIONS)
    • INCREASING LIFE EXPECTANCY
    • TABLE 12 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2013 (YEARS)
    • FIGURE 7 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2013 (YEARS)
    • ECONOMICS AND HEALTHCARE
    • TABLE 13 HEALTH EXPENDITURES AS PERCENTAGE OF GDP BY SELECT COUNTRY, 1980-2015 (%)
    • FIGURE 8 HEALTH EXPENDITURES AS PERCENTAGE OF GDP BY SELECT COUNTRY, 1980-2015 (%)
    • ECONOMIC IMPACT OF WOUNDS AND WOUND MANAGEMENT
  • GOVERNMENT REGULATION OF DEVICES
  • INTERNATIONAL STEM CELL RESEARCH

CHAPTER 5 TECHNOLOGY AND NEW DEVELOPMENTS

  • NEW DEVELOPMENTS AND RESEARCH
    • STEM CELL RESEARCH
    • GENE THERAPY
    • LIGHT-EMITTING DIODES
      • Light-emitting Diodes in Conjunction with Laser Diodes
      • TABLE 14 SELECT COMPANIES OFFERING LIGHT-EMITTING DIODE DEVICES FOR WOUND MANAGEMENT
    • IN VIVO VS IN VITRO
    • TABLE 15 ADVANTAGES OF IN VIVO AND IN VITRO TISSUE GROWTH
    • IN VITRO
    • IN VIVO
  • MILITARY WOUND MANAGEMENT
    • BATTLEFIELD WOUND TREATMENT
      • One-Handed Tourniquet
      • Natural Fiber Bandages
      • Accelerated Blood-Clotting Products
      • High-tech Bandages
      • Mobile Medical Tents
      • Wound-Filler Hemostasis Products
  • ALTERNATIVE WOUND THERAPY
    • MAGGOT THERAPY
      • Reimbursement for Maggot Therapy [1]
    • LEECH THERAPY
    • APITHERAPY
  • TECHNOLOGY
    • CURRENT TECHNOLOGY USES
      • Negative Pressure Technology
      • Tissue-engineered Skin Substitutes
      • Tissue Regeneration
      • ACell-MatriStem
      • Darco International Inc.
  • PATENT ANALYSIS
  • TABLE 16 WOUND CARE/MANAGEMENT TECHNOLOGY PATENT GROWTH, 1979-2014 (NO./%)
  • FIGURE 9 WOUND CARE/MANAGEMENT TECHNOLOGY PATENT GROWTH (NO.)
  • TABLE 17 WOUND MANAGEMENT TECHNOLOGY PATENTS BY YEAR, 1979-2014*
  • FIGURE 10 WOUND MANAGEMENT TECHNOLOGY PATENTS BY YEAR, 1979-2014*
  • TABLE 18 U.S. PATENTS, SELECTED DEVELOPERS AND WOUND CARE-RELATED TECHNOLOGIES
  • TABLE 19 ADVANCED WOUND MANAGEMENT RELATED TECHNOLOGIES BY PATENT HOLDER, JANUARY 1, 2013-MARCH 18, 2014 (15 MONTHS)
  • FIGURE 11 ADVANCED WOUND MANAGEMENT RELATED TECHNOLOGIES BY PATENT HOLDER, JANUARY 1, 2013-MARCH 18, 2014 (15 MONTHS)

CHAPTER 6 MARKET SEGMENTS

  • ADVANCED DRESSING TECHNOLOGIES
  • TABLE 20 GLOBAL MARKET REVENUES FOR ADVANCED DRESSING TECHNOLOGIES, THROUGH 2018 ($ MILLIONS)
  • FIGURE 12 GLOBAL MARKET REVENUES FOR ADVANCED DRESSING TECHNOLOGIES, 2011-2018 ($ MILLIONS)
    • BIOLOGICAL WOUND HEALING
      • Product Description
        • Artificial Skin/Skin Replacement
        • TABLE 21 MANUFACTURERS OF ARTIFICIAL SKIN/SKIN REPLACEMENT DRESSINGS, 2013
          • Kinetic Concepts
          • Organogenesis
          • Smith & Nephew
          • Shire Regenerative Medicine
          • Genzyme
          • Integra Life Sciences
          • LifeCell (Kinetic Concepts)
        • Collagen Products
      • TABLE 22 MANUFACTURERS OF COLLAGEN DRESSINGS, 2013
        • Smith & Nephew
        • Kinetic Concepts
        • Integra Life Sciences
        • Forticell BioScience Inc.
        • DermaRite Industries
        • Cardium Therapeutics
        • TEI Biosciences
        • Southwest Technologies Inc.
        • Systagenix (Kinetic Concepts)
        • Medline Industries
        • Baxter International
        • Synovis Surgical Innovations
      • Growth Factors
      • TABLE 23 MANUFACTURERS OF GROWTH FACTOR WOUND MANAGEMENT TECHNOLOGIES, 2013
        • Smith & Nephew
        • Cytomedix
        • Molnylcke
    • Products in development
    • TABLE 24 SELECT BIOLOGIC PRODUCTS IN DEVELOPMENT, 2013
    • Market Analysis and Conclusion
      • Total Market and Segments
      • TABLE 25 GLOBAL MARKET REVENUES FOR BIOLOGICAL TECHNOLOGIES BY PRODUCT SEGMENT, THROUGH 2018 ($ MILLIONS)
      • FIGURE 13 GLOBAL MARKET REVENUES FOR BIOLOGICAL TECHNOLOGIES BY PRODUCT SEGMENT, 2011-2018 ($ MILLIONS)
      • TABLE 26 DISTRIBUTION OF REVENUES FOR BIOLOGICAL TECHNOLOGIES BY WOUND TYPE, 2013 (%/$ MILLIONS)
      • FIGURE 14 DISTRIBUTION OF REVENUES FOR BIOLOGICAL DRESSINGS BY WOUND TYPE, 2013 (%)
      • TABLE 27 SUMMARY OF BIOLOGICAL DRESSINGS MARKET BY COMPETITOR REVENUES, 2013 (%/$ MILLIONS)
      • FIGURE 15 SUMMARY OF BIOLOGICAL DRESSINGS MARKET BY COMPETITOR REVENUES, 2013 ($ MILLIONS)
    • SYNTHETIC DRESSINGS
      • Product Description
      • Alginate Dressings
      • TABLE 28 ALGINATE DRESSING MANUFACTURERS, 2013 5
      • Film Dressings
      • TABLE 29 FILM DRESSING MANUFACTURERS, 2013
      • Foam Dressings
      • TABLE 30 FOAM DRESSING MANUFACTURERS, 2013
      • Hydrocolloid Dressings
      • TABLE 31 HYDROCOLLOID DRESSING MANUFACTURERS, 2013
      • Hydrogel Dressings
      • TABLE 32 HYDROGEL DRESSING MANUFACTURERS, 2013
      • Market analysis and conclusion
        • Total Market and Segments
        • TABLE 33 GLOBAL MARKET REVENUES FOR SYNTHETIC TECHNOLOGIES BY PRODUCT SEGMENT, THROUGH 2018
        • FIGURE 16 GLOBAL MARKET REVENUES FOR SYNTHETIC TECHNOLOGIES BY PRODUCT SEGMENT, THROUGH 2018 ($ MILLIONS)
        • TABLE 34 REVENUE DISTRIBUTION FOR SYNTHETIC TECHNOLOGIES BY WOUND TYPE, 2013 ($ MILLIONS)
        • FIGURE 17 REVENUE DISTRIBUTION FOR SYNTHETIC TECHNOLOGIES BY WOUND TYPE, 2013 (%)
        • Competitive Summary
        • TABLE 35 SUMMARY OF SYNTHETIC TECHNOLOGIES BY COMPETITOR REVENUES, 2013 ($ MILLIONS)
        • FIGURE 18 SUMMARY OF SYNTHETIC TECHNOLOGIES BY COMPETITOR REVENUES, 2013 ($ MILLIONS)
    • NATURAL DRESSINGS
      • Product Description
      • TABLE 36 ALGINATE DRESSING MANUFACTURERS, 2013
        • Derma Sciences
        • DeRoyal Industries
        • Smith & Nephew
        • Medline Industries
        • Braun
        • Covidien
        • DermaRite
        • Systagenix (Kinetic Concepts)
        • Gentell Corp.
        • ConvaTec
        • Molnlycke Health Care
        • Hollister Wound Care
        • Coloplast
        • Hartmann Group
        • Mylan
        • 3M Health Care
      • Market Analysis And Conclusions
        • Total Market and Segments
        • TABLE 37 GLOBAL MARKET REVENUES FOR NATURAL TECHNOLOGIES, THROUGH 2018 ($ MILLIONS)
        • FIGURE 19 GLOBAL MARKET REVENUES FOR NATURAL TECHNOLOGIES, 2011-2018 ($ MILLIONS)
        • TABLE 38 REVENUE DISTRIBUTION FOR NATURAL DRESSINGS BY WOUND TYPE, 2013 (%/$ MILLIONS)
        • FIGURE 20 REVENUE DISTRIBUTION FOR NATURAL DRESSINGS BY WOUND TYPE, 2013 (%)
        • TABLE 39 SUMMARY OF NATURAL DRESSING TECHNOLOGIES MARKET BY COMPETITOR REVENUES, 2013 (%/$ MILLIONS)
        • FIGURE 21 SUMMARY OF NATURAL DRESSING TECHNOLOGIES MARKET BY COMPETITOR REVENUES, 2013 ($ MILLIONS)
  • SURGICAL SEALANTS AND GLUES
    • PRODUCT DESCRIPTIONS
    • TABLE 40 MANUFACTURERS OF SURGICAL SEALANTS AND GLUES, 2011
      • Advanced Medical Solutions plc
      • Baxter
      • Integra Life Sciences
      • Cohera Medical
      • CryoLife Inc.
      • Johnson & Johnson
      • Davol/CR Bard.
      • Ocular Therapeutic Inc.
      • Takeda
      • Tenaxis Medical
      • Tissuemed Ltd.
      • TissueSeal LLC
    • PRODUCTS IN DEVELOPMENT
    • TABLE 41 SELECT SURGICAL/VASCULAR SEALANT PRODUCTS IN DEVELOPMENT
    • MARKET ANALYSIS AND CONCLUSIONS
      • Total Market and Segments
      • TABLE 42 GLOBAL MARKET REVENUES FOR SURGICAL SEALANTS AND GLUES, THROUGH 2018 ($ MILLIONS)
      • FIGURE 22 GLOBAL MARKET REVENUES FOR SURGICAL SEALANTS AND GLUES, 2011-2018 ($ MILLIONS)
      • Competitive Summary
      • TABLE 43 SUMMARY OF THE GLOBAL SURGICAL SEALANTS AND GLUES MARKET BY COMPETITOR REVENUES, 2013 ($ MILLIONS)
      • FIGURE 23 SUMMARY OF THE GLOBAL SURGICAL SEALANTS AND GLUES MARKET BY COMPETITOR REVENUES, 2013 ($ MILLIONS)
  • ANTI-ADHESION AND OTHER RELATED WOUND HEALING PRODUCTS
    • ANTI-ADHESION PRODUCTS
    • ENZYMATIC/HYPERTONIC SALINE DEBRIDING AGENTS
    • PRODUCT DESCRIPTION
    • TABLE 44 MANUFACTURERS OF ANTI-ADHESION AND OTHER ADVANCED WOUND MANAGEMENT PRODUCTS, 2013
      • Adhesion Barriers
      • TABLE 45 SURGEON EXPERIENCES WITH THE THREE LEADING ADHESION BARRIERS IN THE UNITED STATES
      • Other Products
    • PRODUCTS IN DEVELOPMENT
    • TABLE 46 SELECT ANTI-ADHESION PRODUCTS AND OTHER ADVANCED WOUND MANAGEMENT PRODUCTS IN DEVELOPMENT
    • MARKET ANALYSIS AND CONCLUSIONS
      • Total Market and Segments
      • TABLE 47 GLOBAL MARKET FOR ANTI-ADHESION AND OTHER WOUND HEALING PRODUCTS BY SEGMENT, THROUGH 2018 ($ MILLIONS)
      • FIGURE 24 GLOBAL MARKET FOR ANTI-ADHESION AND OTHER WOUND HEALING PRODUCTS BY SEGMENT, THROUGH 2018 ($ MILLIONS)
      • Markets by Wound Type
      • TABLE 48 REVENUE DISTRIBUTION FOR ANTI-ADHESION AND OTHER WOUND HEALING PRODUCTS BY WOUND TYPE, 2013 (%/$ MILLIONS)
      • FIGURE 25 REVENUE DISTRIBUTION FOR ANTI-ADHESION AND OTHER WOUND HEALING PRODUCTS BY WOUND TYPE, 2013 (%)
      • Competitive Summary
      • TABLE 49 SUMMARY OF GLOBAL ANTI-ADHESION AND OTHER WOUND HEALING MARKETS BY COMPETITOR REVENUES, 2013 (%/$ MILLIONS)
      • FIGURE 26 SUMMARY OF GLOBAL ANTI-ADHESION AND OTHER WOUND HEALING MARKETS BY COMPETITOR REVENUES, 2013 ($ MILLIONS)
  • WOUND HEALING DEVICES
    • PRODUCT DESCRIPTIONS
    • TABLE 50 ADVANCED WOUND HEALING DEVICES, 2013
      • Electrical Stimulation Devices and Electromagnetic Therapy
      • Electromagnetic Therapy
      • Negative Pressure Wound Therapy (NPWT) or Vacuum Assisted Closure (V.A.C.)
      • Hyperbaric Oxygen Devices
      • EpiFLO (Transdermal Sustained Oxygen Delivery)
      • Radio Frequency (RF) Stimulus
      • External Tissue Expander (Proxiderm)
      • Ultrasonic Wound Debridement
      • LED Therapy
      • Other Devices
    • MARKET ANALYSIS AND CONCLUSION
      • Total Market and Segments
      • TABLE 51 GLOBAL MARKET FOR WOUND HEALING DEVICES BY PRODUCT SEGMENT, THROUGH 2018 ($ MILLIONS)
      • FIGURE 27 GLOBAL MARKET FOR WOUND HEALING DEVICES BY PRODUCT SEGMENT, THROUGH 2018 ($ MILLIONS)
      • Markets by Wound Type
      • TABLE 52 REVENUE DISTRIBUTION FOR WOUND HEALING DEVICES BY WOUND TYPE, 2013 (%/$ MILLIONS)
      • FIGURE 28 REVENUE DISTRIBUTION FOR WOUND HEALING DEVICES BY WOUND TYPE, 2013 (%)
      • Competitive Summary
      • TABLE 53 SUMMARY OF THE GLOBAL WOUND HEALING DEVICE MARKET BY COMPETITOR REVENUES, 2013 (%/$ MILLIONS)
      • FIGURE 29 SUMMARY OF THE GLOBAL WOUND HEALING DEVICE MARKET BY COMPETITOR REVENUES, 2013 ($ MILLIONS)

CHAPTER 7 MARKET SUMMARY

  • TOTAL ADVANCED WOUND MANAGEMENT MARKET ANALYSIS
  • TABLE 54 GLOBAL ANALYSIS-MARKET FOR ADVANCED WOUND MANAGEMENT PRODUCTS BY TYPE, THROUGH 2018 ($ MILLIONS) 18
  • FIGURE 30 GLOBAL ANALYSIS-MARKET FOR ADVANCED WOUND MANAGEMENT PRODUCTS BY TYPE, 2011-2018 ($ MILLIONS)
  • FIGURE 31 GLOBAL ANALYSIS-MARKET FOR ADVANCED WOUND MANAGEMENT PRODUCTS, DISTRIBUTION BY PRODUCT TYPE, 2013 (%)
  • MARKETS BY WOUND TYPE
  • TABLE 55 REVENUE DISTRIBUTION BY TYPE OF ADVANCED WOUND MANAGEMENT, 2013 (%/$ MILLIONS)
  • FIGURE 32 REVENUE DISTRIBUTION BY TYPE OF ADVANCED WOUND MANAGEMENT, 2013 ($ MILLIONS)
  • GLOBAL MARKETS BY REGION
  • TABLE 56 REGIONAL MARKET ANALYSIS-ADVANCED WOUND MANAGEMENT, THROUGH 2018 ($ MILLIONS)
  • FIGURE 33 PERCENT DISTRIBUTION OF THE TOTAL WOUND MANAGEMENT MARKET BY REGION, 2013 (%)
  • INDUSTRY PARTICIPANTS BY TYPE
  • TABLE 57 MAJOR INDUSTRY PARTICIPANTS BY PRODUCT TYPE

CHAPTER 8 COMPANY PROFILES AND SNAPSHOTS

  • 3M HEALTH CARE
  • BARD MEDICAL DIVISION
  • BAXTER INTERNATIONAL INC.
  • COLOPLAST A/S
  • CONVATEC INC.
  • COVIDIEN PLC
  • CRYOLIFE INC.
  • DERMA SCIENCES INC.
  • ETHICON INC.
  • GENZYME BIOSURGERY-A SANOFI COMPANY
  • HARTMANN GROUP
  • INTEGRA LIFE SCIENCES CORP.
  • KINETIC CONCEPTS INC. (LIFECELL)
  • ORGANOGENESIS INC.
  • MOLNLYCKE HEALTH CARE
  • SHIRE REGENERATIVE MEDICINE
  • SMITH & NEPHEW PLC

CHAPTER 9 APPENDIX: INFORMATION SOURCES

LIST OF TABLES

  • SUMMARY TABLE GLOBAL ADVANCED WOUND MANAGEMENT MARKET BY MAJOR MARKET SEGMENT, THROUGH 2018 ($ MILLIONS)
  • TABLE 1 PERCENT OF SMOKERS IN THE U.S. POPULATION 18 AND OLDER BY AGE AND GENDER, 2009
  • TABLE 2 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 1900-2050 (THOUSANDS)
  • TABLE 3 ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH WITH PROJECTIONS BY GENDER, 2000 AND 2020 (YEARS)
  • TABLE 4 PATIENT HISTORY FOR NUTRITIONAL ASSESSMENT
  • TABLE 5 SURGICAL WOUND CLASSIFICATIONS
  • TABLE 6 COMMON SITES FOR PRESSURE ULCER DEVELOPMENT (% OF OCCURRENCE)
  • TABLE 7 PRESSURE ULCER STAGING
  • TABLE 8 BURN CLASSIFICATIONS
  • TABLE 9 ESTIMATED INCIDENCE BY AGE GROUP AND WOUND TYPE (% DISTRIBUTION)
  • TABLE 10 GLOBAL POPULATION BY SELECTED COUNTRY, THROUGH 2015 ($ MILLIONS)
  • TABLE 11 ESTIMATED GLOBAL POPULATION AND ANNUAL GROWTH BY SELECTED AGE GROUP AND SELECTED YEARS, THROUGH 2030 ($ MILLIONS)
  • TABLE 12 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2013 (YEARS)
  • TABLE 13 HEALTH EXPENDITURES AS PERCENTAGE OF GDP BY SELECT COUNTRY, 1980-2015 (%)
  • TABLE 14 SELECT COMPANIES OFFERING LIGHT-EMITTING DIODE DEVICES FOR WOUND MANAGEMENT
  • TABLE 15 ADVANTAGES OF IN VIVO AND IN VITRO TISSUE GROWTH
  • TABLE 16 WOUND CARE/MANAGEMENT TECHNOLOGY PATENT GROWTH, 1979-2014 (NO./%)
  • TABLE 17 WOUND MANAGEMENT TECHNOLOGY PATENTS BY YEAR, 1979-2014*
  • TABLE 18 U.S. PATENTS, SELECTED DEVELOPERS AND WOUND CARE-RELATED TECHNOLOGIES
  • TABLE 19 ADVANCED WOUND MANAGEMENT RELATED TECHNOLOGIES BY PATENT HOLDER, JANUARY 1, 2013-MARCH 18, 2014 (15 MONTHS)
  • TABLE 20 GLOBAL MARKET REVENUES FOR ADVANCED DRESSING TECHNOLOGIES, THROUGH 2018 ($ MILLIONS)
  • TABLE 21 MANUFACTURERS OF ARTIFICIAL SKIN/SKIN REPLACEMENT DRESSINGS, 2013
  • TABLE 22 MANUFACTURERS OF COLLAGEN DRESSINGS, 2013
  • TABLE 23 MANUFACTURERS OF GROWTH FACTOR WOUND MANAGEMENT TECHNOLOGIES, 2013
  • TABLE 24 SELECT BIOLOGIC PRODUCTS IN DEVELOPMENT, 2013
  • TABLE 25 GLOBAL MARKET REVENUES FOR BIOLOGICAL TECHNOLOGIES BY PRODUCT SEGMENT, THROUGH 2018 ($ MILLIONS)
  • TABLE 26 DISTRIBUTION OF REVENUES FOR BIOLOGICAL TECHNOLOGIES BY WOUND TYPE, 2013 (%/$ MILLIONS)
  • TABLE 27 SUMMARY OF BIOLOGICAL DRESSINGS MARKET BY COMPETITOR REVENUES, 2013 (%/$ MILLIONS)
  • TABLE 28 ALGINATE DRESSING MANUFACTURERS, 2013
  • TABLE 29 FILM DRESSING MANUFACTURERS, 2013
  • TABLE 30 FOAM DRESSING MANUFACTURERS, 2013
  • TABLE 31 HYDROCOLLOID DRESSING MANUFACTURERS, 2013 17
  • TABLE 32 HYDROGEL DRESSING MANUFACTURERS, 2013
  • TABLE 33 GLOBAL MARKET REVENUES FOR SYNTHETIC TECHNOLOGIES BY PRODUCT SEGMENT, THROUGH 2018
  • TABLE 34 REVENUE DISTRIBUTION FOR SYNTHETIC TECHNOLOGIES BY WOUND TYPE, 2013 ($ MILLIONS)
  • TABLE 35 SUMMARY OF SYNTHETIC TECHNOLOGIES BY COMPETITOR REVENUES, 2013 ($ MILLIONS)
  • TABLE 36 ALGINATE DRESSING MANUFACTURERS, 2013
  • TABLE 37 GLOBAL MARKET REVENUES FOR NATURAL TECHNOLOGIES, THROUGH 2018 ($ MILLIONS)
  • TABLE 38 REVENUE DISTRIBUTION FOR NATURAL DRESSINGS BY WOUND TYPE, 2013 (%/$ MILLIONS)
  • TABLE 39 SUMMARY OF NATURAL DRESSING TECHNOLOGIES MARKET BY COMPETITOR REVENUES, 2013 (%/$ MILLIONS)
  • TABLE 40 MANUFACTURERS OF SURGICAL SEALANTS AND GLUES, 2011
  • TABLE 41 SELECT SURGICAL/VASCULAR SEALANT PRODUCTS IN DEVELOPMENT
  • TABLE 42 GLOBAL MARKET REVENUES FOR SURGICAL SEALANTS AND GLUES, THROUGH 2018 ($ MILLIONS)
  • TABLE 43 SUMMARY OF THE GLOBAL SURGICAL SEALANTS AND GLUES MARKET BY COMPETITOR REVENUES, 2013 ($ MILLIONS)
  • TABLE 44 MANUFACTURERS OF ANTI-ADHESION AND OTHER ADVANCED WOUND MANAGEMENT PRODUCTS, 2013
  • TABLE 45 SURGEON EXPERIENCES WITH THE THREE LEADING ADHESION BARRIERS IN THE UNITED STATES
  • TABLE 46 SELECT ANTI-ADHESION PRODUCTS AND OTHER ADVANCED WOUND MANAGEMENT PRODUCTS IN DEVELOPMENT
  • TABLE 47 GLOBAL MARKET FOR ANTI-ADHESION AND OTHER WOUND HEALING PRODUCTS BY SEGMENT, THROUGH 2018 ($ MILLIONS)
  • TABLE 48 REVENUE DISTRIBUTION FOR ANTI-ADHESION AND OTHER WOUND HEALING PRODUCTS BY WOUND TYPE, 2013 (%/$ MILLIONS)
  • TABLE 49 SUMMARY OF GLOBAL ANTI-ADHESION AND OTHER WOUND HEALING MARKETS BY COMPETITOR REVENUES, 2013 (%/$ MILLIONS)
  • TABLE 50 ADVANCED WOUND HEALING DEVICES, 2013
  • TABLE 51 GLOBAL MARKET FOR WOUND HEALING DEVICES BY PRODUCT SEGMENT, THROUGH 2018 ($ MILLIONS)
  • TABLE 52 REVENUE DISTRIBUTION FOR WOUND HEALING DEVICES BY WOUND TYPE, 2013 (%/$ MILLIONS)
  • TABLE 53 SUMMARY OF THE GLOBAL WOUND HEALING DEVICE MARKET BY COMPETITOR REVENUES, 2013 (%/$ MILLIONS)
  • TABLE 54 GLOBAL ANALYSIS-MARKET FOR ADVANCED WOUND MANAGEMENT PRODUCTS BY TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 55 REVENUE DISTRIBUTION BY TYPE OF ADVANCED WOUND MANAGEMENT, 2013 (%/$ MILLIONS)
  • TABLE 56 REGIONAL MARKET ANALYSIS-ADVANCED WOUND MANAGEMENT, THROUGH 2018 ($ MILLIONS)
  • TABLE 57 MAJOR INDUSTRY PARTICIPANTS BY PRODUCT TYPE

LIST OF FIGURES

  • SUMMARY FIGURE GLOBAL ADVANCED WOUND MANAGEMENT MARKET BY MAJOR MARKET SEGMENT, 2011-2018 ($ MILLIONS)
  • FIGURE 1 SKIN LAYERS 12
  • FIGURE 2 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 1900-2050 (THOUSANDS)
  • FIGURE 3 ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH WITH PROJECTIONS BY GENDER, 2000 AND 2020 (YEARS)
  • FIGURE 4 ESTIMATED INCIDENCE BY AGE GROUP AND WOUND TYPE (% DISTRIBUTION)
  • FIGURE 5 GLOBAL POPULATION BY SELECTED COUNTRY, 2010 AND 2015 (MILLIONS)
  • FIGURE 6 ESTIMATED GLOBAL POPULATION BY SELECTED AGE GROUP AND SELECTED YEARS, 2000-2030 (MILLIONS)
  • FIGURE 7 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2013 (YEARS)
  • FIGURE 8 HEALTH EXPENDITURES AS PERCENTAGE OF GDP BY SELECT COUNTRY, 1980-2015 (%)
  • FIGURE 9 WOUND CARE/MANAGEMENT TECHNOLOGY PATENT GROWTH (NO.)
  • FIGURE 10 WOUND MANAGEMENT TECHNOLOGY PATENTS BY YEAR, 1979-2014*
  • FIGURE 11 ADVANCED WOUND MANAGEMENT RELATED TECHNOLOGIES BY PATENT HOLDER, JANUARY 1, 2013-MARCH 18, 2014 (15 MONTHS)
  • FIGURE 12 GLOBAL MARKET REVENUES FOR ADVANCED DRESSING TECHNOLOGIES, 2011-2018 ($ MILLIONS)
  • FIGURE 13 GLOBAL MARKET REVENUES FOR BIOLOGICAL TECHNOLOGIES BY PRODUCT SEGMENT, 2011-2018 ($ MILLIONS)
  • FIGURE 14 DISTRIBUTION OF REVENUES FOR BIOLOGICAL DRESSINGS BY WOUND TYPE, 2013 (%)
  • FIGURE 15 SUMMARY OF BIOLOGICAL DRESSINGS MARKET BY COMPETITOR REVENUES, 2013 ($ MILLIONS)
  • FIGURE 16 GLOBAL MARKET REVENUES FOR SYNTHETIC TECHNOLOGIES BY PRODUCT SEGMENT, THROUGH 2018 ($ MILLIONS)
  • FIGURE 17 REVENUE DISTRIBUTION FOR SYNTHETIC TECHNOLOGIES BY WOUND TYPE, 2013 (%)
  • FIGURE 18 SUMMARY OF SYNTHETIC TECHNOLOGIES BY COMPETITOR REVENUES, 2013 ($ MILLIONS)
  • FIGURE 19 GLOBAL MARKET REVENUES FOR NATURAL TECHNOLOGIES, 2011-2018 ($ MILLIONS)
  • FIGURE 20 REVENUE DISTRIBUTION FOR NATURAL DRESSINGS BY WOUND TYPE, 2013 (%)
  • FIGURE 21 SUMMARY OF NATURAL DRESSING TECHNOLOGIES MARKET BY COMPETITOR REVENUES, 2013 ($ MILLIONS)
  • FIGURE 22 GLOBAL MARKET REVENUES FOR SURGICAL SEALANTS AND GLUES, 2011-2018 ($ MILLIONS)
  • FIGURE 23 SUMMARY OF THE GLOBAL SURGICAL SEALANTS AND GLUES MARKET BY COMPETITOR REVENUES, 2013 ($ MILLIONS)
  • FIGURE 24 GLOBAL MARKET FOR ANTI-ADHESION AND OTHER WOUND HEALING PRODUCTS BY SEGMENT, THROUGH 2018 ($ MILLIONS)
  • FIGURE 25 REVENUE DISTRIBUTION FOR ANTI-ADHESION AND OTHER WOUND HEALING PRODUCTS BY WOUND TYPE, 2013 (%)
  • FIGURE 26 SUMMARY OF GLOBAL ANTI-ADHESION AND OTHER WOUND HEALING MARKETS BY COMPETITOR REVENUES, 2013 ($ MILLIONS)
  • FIGURE 27 GLOBAL MARKET FOR WOUND HEALING DEVICES BY PRODUCT SEGMENT, THROUGH 2018 ($ MILLIONS)
  • FIGURE 28 REVENUE DISTRIBUTION FOR WOUND HEALING DEVICES BY WOUND TYPE, 2013 (%)
  • FIGURE 29 SUMMARY OF THE GLOBAL WOUND HEALING DEVICE MARKET BY COMPETITOR REVENUES, 2013 ($ MILLIONS)
  • FIGURE 30 GLOBAL ANALYSIS-MARKET FOR ADVANCED WOUND MANAGEMENT PRODUCTS BY TYPE, 2011-2018 ($ MILLIONS) 1
  • FIGURE 31 GLOBAL ANALYSIS-MARKET FOR ADVANCED WOUND MANAGEMENT PRODUCTS, DISTRIBUTION BY PRODUCT TYPE, 2013 (%)
  • FIGURE 32 REVENUE DISTRIBUTION BY TYPE OF ADVANCED WOUND MANAGEMENT, 2013 ($ MILLIONS)
  • FIGURE 33 PERCENT DISTRIBUTION OF THE TOTAL WOUND MANAGEMENT MARKET BY REGION, 2013 (%)
Back to Top